Lung cancer has become the number of patients of malignant tumors

The third population of the National Death reason sampling survey: Cancer has become the first cause of death in China's urban residents, accounting for 25% of all deaths. The lung has become a malignant tumor the number of patients first.

Capital University of Medical Diagnosis and Treatment of Lung Cancer Center Deputy Director, Capital Medical University, Beijing Chaoyang Hospital, director of thoracic surgery, vice chairman of the Professional Committee of the Beijing Medical Thoracic Surgery Professor Li Hui in the recently initiated by the Chinese Cancer Fund tobacco control and lung cancer prevention and control of the Ministry of supported by AstraZeneca (China), "Caring for lung cancer - a better life 'easy' up" lung cancer prevention promotional activities that: China has become the number of patients of malignant tumors, such tumor is primary in the lung, malignant tumor of the trachea and bronchi, diagnosed more than advanced, prevention of the consequences of unsatisfactory progress very rapidly and so on.

The main cause of lung cancer is smoking, worldwide since the 1950s has been a large number of epidemiological studies confirm that smoking is the primary cause of lung cancer risk factors in the patients who died due to lung cancer, 87% by Smoking (including passive smoking). Male smokers of lung cancer death rate is 8 to 20 times the non-smokers.

Very few symptoms of early stage lung cancer, patient visits are mostly in the late results were poor. Thus early detection, early diagnosis and early treatment is to improve the cure rate of lung cancer.

Therefore, on the basis of scientific prevention, prevention has become particularly important. The scientific mode of treatment can completely affect the whole way of life in patients after starting treatment.

Traditional chemotherapy seriously affect the quality of life of patients

Currently the main treatment for advanced lung cancer is the traditional treatment modalities of chemotherapy treatment. Effective chemotherapy can improve survival of patients, but associated with significant side effects such as nausea, vomiting, hair loss , leukopenia, lowered immunity, fatigue, neuropathy, etc., and the need for intravenous therapy, patients are often hospitalized for treatment, seriously affecting the quality of life of patients. Patients are often "chemotherapy chemotherapy of when is?" Questions.

Long-term chemotherapy and repeated hospitalization was the only option in order to control the tumor and prolong survival of patients with advanced non-small cell lung cancer. Moreover, even the best efficacy of chemotherapy, only about 30-35% of patients the efficacy of tumor shrinkage. Bear so much pain for the remaining six, 70% of patients, but no noticeable effect, like to accompany tied down "treatment. These patients need to have an alternative so that they can enjoy every moment of the good old days of the life like a normal face the threat of advanced tumors.

Oral individual targeted drugs gefitinib clinical application of the Nepalese completely changed the impact of chemotherapy on patients' lives.

With the rapid development of molecular targeted therapies and clinical widely used, its safety and tolerability is better, more precise clinical efficacy of a specific beneficiary population, the treatment of advanced non-small cell lung cancer patients converted to chronic lifestyle mode of treatment of the disease, make us a few decades, advocacy and work with survival possible.

Professor Li Hui introduced to: The face of the latest achievements of scientific research, more doctors and patients recognize tumor treatment, there is another better option to get rid of the inherent concept of a single chemotherapy and together try new things. step.

At the same time, Zhi Xiuyi professor pointed out that oral targeted therapy gefitinib Nepalese application and a strong clinical research data continue to emerge, changed the traditional treatment of advanced non-small cell lung cancer and mode of thinking. Chemotherapy is no longer patients the only option. With more effective drugs in the clinical applications, advanced non-small cell lung cancer patient survival has been a significant extension. I believe that as medical progress and development of advanced non-small cell mode of treatment of lung cancer will be more humane and individualized may even be in the near future, non-small cell lung cancer will be successful control is no longer a people terrified of the killer, like hypertension and diabetes, like long-term control steady state of chronic disease so that people will no longer "talk about cancer discoloration."

It was reported that after the successful conclusion of the promotional activities in Beijing, the route would have been in Shanghai, Guangzhou, Hangzhou, Chengdu, Shenyang, Jinan, China's seven major cities to start.